Table of Contents
The National Institute for Health and Care Research has awarded £1.65 million to 17 pioneering projects aimed at accelerating the development of quantum technologies that could transform patient care across the NHS, marking a significant expansion of NIHR quantum technologies NHS investment. The funding will support early-stage innovations designed to tackle some of healthcare’s most complex challenges, from earlier cancer diagnosis to advanced intensive care monitoring.
How This NIHR Quantum Technologies NHS Funding Is Structured
The investment has been made through the NIHR’s Invention for Innovation Funding At the Speed of Translation programme, which brings together leading quantum researchers, clinical experts and NIHR infrastructure to help promising technologies move more rapidly towards adoption in the NHS. The initiative also involves the two NIHR co-funded healthcare quantum research hubs, Q-BIOMED and QuSIT, alongside NHS research infrastructure specialising in quantum innovation.
A Broad Range of Healthcare Applications
The 17 funded projects span a broad range of healthcare applications, demonstrating the growing potential of quantum technologies to improve diagnosis, treatment and patient outcomes.
Standout Projects Within This NIHR Quantum Technologies NHS Initiative
Among the projects receiving support is breast cancer imaging research at Imperial College London, where researchers are using so-called “undetected photons” to create faster, noise-free images. The technology could help clinicians make more informed treatment decisions, reducing unnecessary chemotherapy and cutting testing costs for the NHS.
Home Monitoring and ICU Risk Prediction
At Heriot-Watt University, scientists are developing a compact device that enables patients with macular disease to monitor their eye health at home, reducing the need for hospital appointments and helping prevent sight loss. At University College London, researchers are creating a hybrid quantum-classical decision support system capable of predicting critical events such as cardiac arrest in intensive care patients, enabling faster and more effective clinical interventions.
Leadership’s Perspective on This NIHR Quantum Technologies NHS Investment
“This funding is a major step forward in bringing quantum technology to patients, cementing the UK as Europe’s leader in quantum health innovation,” said Professor Mike Lewis, NIHR Scientific Director for Innovation. “By investing in these 17 projects, we are fast-tracking tools that can diagnose illness earlier and provide life-changing breakthroughs. These innovations will transform our health system and improve the lives of patients.”
The Government’s View on Quantum’s Potential
“Quantum technology has the potential to transform the way we prevent, diagnose and treat disease, helping patients receive faster, better care while supporting our mission to build an NHS fit for the future,” said Health and Social Care Minister Baroness Gillian Merron. “Through this £1.65 million investment, we’re backing some of the UK’s brightest researchers to turn cutting-edge science into practical innovations that could help detect cancer earlier, support people to monitor long-term conditions from home, and give clinicians better tools to make life-saving decisions.”
How This NIHR Quantum Technologies NHS Push Fits Broader UK Ambitions
The latest funding forms part of the wider government ambition to modernise healthcare through advanced technologies and support the NHS’s transition from analogue systems to digital healthcare delivery. Government plans set out in 2026 aim to position the UK as the first nation to deploy quantum computing at scale by the early 2030s, with the potential to contribute up to £200 billion to the UK economy by 2045.
Building a Pipeline of Clinically Relevant Technologies
Many of the newly funded projects focus on detecting disease earlier, improving clinical decision-making and shifting care closer to patients’ homes. By supporting these innovations at an early stage, the NIHR hopes to create a strong pipeline of clinically relevant technologies capable of attracting further investment, supporting UK businesses and researchers, and ultimately improving productivity and outcomes across the NHS.
What This NIHR Quantum Technologies NHS Investment Means Going Forward
As quantum research moves closer to real-world healthcare applications, this funding signals growing confidence that the technology could become a major driver of future medical breakthroughs and NHS transformation. Given the government’s stated ambition to deploy quantum computing at scale by the early 2030s, these 17 early-stage projects may serve as an important proving ground for demonstrating clinical value before broader national rollout.
What to Watch Going Forward
As these 17 projects progress from early-stage development toward potential clinical adoption, industry observers will likely watch which technologies, such as the Imperial College London breast cancer imaging work or the University College London ICU prediction system, first demonstrate measurable patient outcomes sufficient to attract further investment. Given the UK’s stated goal of becoming Europe’s leader in quantum health innovation, the success of this NIHR quantum technologies NHS funding round could shape how quickly quantum-enabled diagnostics and clinical decision support tools move from research hubs into everyday NHS practice.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
